Abstract

The potential impact of the composition of maternal breast milk is poorly known in children who develop celiac disease (CD). The aim of our study was to compare the microbiota composition and the concentrations of immune markers in breast milk from mothers whose offspring carried the genetic predisposition to CD, and whether they did or did not develop CD during follow-up for the first 3 years of life. Maternal breast milk samples [CD children (n = 6) and healthy children (n = 18)] were collected 3 months after delivery. Enzyme-linked immunosorbent assays were used to measure TGF-β1, TGF-β2, sIgA, MFG-E8 and sCD14. For microbiota analysis, next generation (Illumina) sequencing, real-time PCR and denaturing gradient gel electrophoresis were used. Phylotype abundance and the Shannon ‘H’ diversity index were significantly higher in breast milk samples in the CD group. There was higher prevalence of the phyla Bacteroidetes and Fusobacteria, the classes Clostridia and Fusobacteriia, and the genera Leptotrichia, Anaerococcus, Sphingomonas, Actynomyces and Akkermansia in the CD group. The immunological markers were differently associated with some Gram-negative bacterial genera and species (Chryseobacterium, Sphingobium) as well as Gram-positive species (Lactobacillusreuteri, Bifidobacteriumanimalis). In conclusion, the microbiota in breast milk from mothers of genetically predisposed offspring who presented CD showed a higher bacterial phylotype abundance and diversity, as well as a different bacterial composition, as compared with the mothers of unaffected offspring. These immune markers showed some associations with bacterial composition and may influence the risk for development of CD beyond early childhood.

Details

Title
Maternal breast milk microbiota and immune markers in relation to subsequent development of celiac disease in offspring
Author
Štšepetova Jelena 1 ; Kärt, Simre 2 ; Tagoma Aili 3 ; Oivi, Uibo 4 ; Peet Aleksandr 4 ; Siljander Heli 5 ; Vallo, Tillmann 4 ; Knip Mikael 6   VIAFID ORCID Logo  ; Reet, Mändar 7 ; Raivo, Uibo 3 

 University of Tartu, Department of Microbiology, Institute of Biomedicine and Translational Medicine, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661) 
 University of Tartu, Department of Immunology, Institute of Biomedicine and Translational Medicine, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661); Tartu University Hospital, Children’s Clinic, Tartu, Estonia (GRID:grid.412269.a) (ISNI:0000 0001 0585 7044) 
 University of Tartu, Department of Immunology, Institute of Biomedicine and Translational Medicine, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661) 
 Tartu University Hospital, Children’s Clinic, Tartu, Estonia (GRID:grid.412269.a) (ISNI:0000 0001 0585 7044); University of Tartu, Department of Pediatrics, Institute of Clinical Medicine, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661) 
 University of Helsinki, Helsinki University Hospital, Pediatric Research Center, Children’s Hospital, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666); University of Helsinki, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Center of Military Medicine, Finnish Defence Forces Logistics Command, Tampere, Finland (GRID:grid.7737.4) 
 University of Helsinki, Helsinki University Hospital, Pediatric Research Center, Children’s Hospital, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666); University of Helsinki, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Tampere University Hospital, Center for Child Health Research, Tampere, Finland (GRID:grid.412330.7) (ISNI:0000 0004 0628 2985) 
 University of Tartu, Department of Microbiology, Institute of Biomedicine and Translational Medicine, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661); Competence Center on Health Technologies, Tartu, Estonia (GRID:grid.10939.32) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2653421939
Copyright
© The Author(s) 2022. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.